Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep;125(6):901-903.
doi: 10.1038/s41416-021-01504-9. Epub 2021 Jul 27.

Insight into the public's interest in tumour treating fields

David J Byun  1 , Aram S Modrek  2 , Erik P Sulman  2   3
Affiliations
Comment

Insight into the public's interest in tumour treating fields

David J Byun et al. Br J Cancer. 2021 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

D.J.B. and A.S.M. have no conflicts of interest to report. E.P.S. has received research support and honoraria from Novocure Ltd.

Figures

Fig. 1
Fig. 1. Relative monthly search volumes from January 2007 to January 2021 for individual Google query terms.
a “tumour treating fields”, “alternating electric field therapy”, vs. known disease site-specific trade names, “Optune” and “Optune Lua”; b “mesothelioma”, “glioblastoma”, vs. “Optune”.
See this image and copyright information in PMC

Comment on

References

    1. Rominiyi O, Vanderlinden A, Clenton SJ, Bridgewater C, Al-Tamimi Y, Collis SJ. Tumour treating fields therapy for glioblastoma: current advances and future directions. Br J Cancer. 2021;124:697–709. doi: 10.1038/s41416-020-01136-5. - DOI - PMC - PubMed
    1. Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, et al. Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA. 2015;314:2535–43. doi: 10.1001/jama.2015.16669. - DOI - PubMed
    1. Ceresoli GL, Aerts JG, Dziadziuszko R, Ramlau R, Cedres S, van Meerbeeck JP, et al. Tumour treating fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial. Lancet Oncol. 2019;20:1702–9. doi: 10.1016/S1470-2045(19)30532-7. - DOI - PubMed
    1. McClelland S, 3rd, Sosanya O, Mitin T, Degnin C, Chen Y, Attia A, et al. Application of tumor treating fields for newly diagnosed glioblastoma: understanding of nationwide practice patterns. J Neurooncol. 2018;140:155–8. doi: 10.1007/s11060-018-2945-y. - DOI - PubMed
    1. Hesse BW, Nelson DE, Kreps GL, Croyle RT, Arora NK, Rimer BK, et al. Trust and sources of health information: the impact of the Internet and its implications for health care providers: findings from the first Health Information National Trends Survey. Arch Intern Med. 2015;165:2618–24. doi: 10.1001/archinte.165.22.2618. - DOI - PubMed